Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
React to this article
Latest news
Date Title
07:31a BANK HAPOALIM : Shimon Peres to Advise Teva Pharmaceuticals in Lucrative Deal
07:31a CITIGROUP : Sinar Mas Land to Raise USD225 Million in Bond Offering Due 2020
07:28a EATON : MILITARY $26,330 Federal Contract Awarded to Eaton
07:28a BOEING : MILITARY $11.1 Million Federal Contract Awarded to Boeing
07:28a PARKER HANNIFIN : MILITARY $85,438 Federal Contract Awarded to Parker-Hannifin
07:28a BP : MILITARY $10.13 Million Federal Contract Awarded to IGI Resources
07:28a PARKER HANNIFIN : MILITARY $48,673 Federal Contract Awarded to Parker-Hannifin
07:28a MERCURY SYSTEMS : MILITARY $91,200 Federal Contract Awarded to Mercury Systems
07:28a PARKER HANNIFIN : MILITARY $61,757 Federal Contract Awarded to Parker-Hannifin
07:28a LOCKHEED MARTIN : MILITARY $40,381 Federal Contract Awarded to Lockheed Martin
Latest news
Advertisement
Hot News 
GCP STUDENT LIVING : Dividend Declaration and Net Asset Valuation
AERIE PHARMACEUTICALS : Pharma plunges aftermarket as Rhopressa study fails
SYQIC : Gets Working Capital Facility Offer, Improves Cash Position
INNATE PHARMA : and AstraZeneca announce global agreement for IPH2201 in immuno-oncology
French Connection warns on full-year results
Most Read News
04/25 DEUTSCHE BANK : to keep 500 German retail branches - Welt am Sonntag
04/25 MANCHESTER UNITED : United aiming to win title next year
04/25 KROGER : accounting celebrates 20 years of growth in Hutchinson
04/25 SOLARCITY : Town of Plattsburgh exploring solar project
04/25 MICROSOFT : Forty Years and a Big Slip
Most recommended articles
06:39a RATAN TATA : India's Ratan Tata buys stake in Chinese phone maker Xiaomi
06:34a Nokia denies return to phone manufacturing
05:54a Nokia denies return to phone manufacturing
05:27aDJGOOGLE : Correction to Mount Everest Avalanche Story
05:22aDJKazakhstan Goes to Polls as President Expected to Win
Dynamic quotes  
ON
| OFF